ADMA Biologics (ADMA) Short Interest Ratio & Short Volume → The only AI company you should be looking at (From Behind the Markets) (Ad) Free ADMA Stock Alerts $5.94 -0.05 (-0.83%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ADMA Biologics Short Interest DataCurrent Short Volume6,720,000 sharesPrevious Short Volume6,150,000 sharesChange Vs. Previous Month+9.27%Dollar Volume Sold Short$36.02 millionShort Interest Ratio / Days to Cover2.6Last Record DateFebruary 29, 2024Outstanding Shares228,220,000 sharesPercentage of Shares Shorted2.94%Today's Trading Volume2,878,603 sharesAverage Trading Volume2,775,256 sharesToday's Volume Vs. Average104% Short Selling ADMA Biologics ? Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADMA Short Interest Over TimeADMA Days to Cover Over TimeADMA Percentage of Float Shorted Over Time Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. ADMA Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36 2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40 1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19 1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99 12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52 12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20 Get the Latest News and Ratings for ADMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADMA Biologics and its competitors with MarketBeat's FREE daily newsletter. 11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70 11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80 10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38 10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21 9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58 9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73 8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85 8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54 7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15 7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57 6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69 6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99 5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07 5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19 4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35 4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18 3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31 3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13 2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55 2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58 1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69 1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40 12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88 12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56 11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34 11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24 10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82 10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62 9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43 9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71 8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70 8/15/202228,270,000 shares $68.13 million -1.7%N/A10.7 $2.41 7/31/202228,760,000 shares $61.55 million +0.1%N/A11.1 $2.14 7/15/202228,730,000 shares $66.08 million +1.3%N/A10.2 $2.30Central Bank Gold Heist In Progress (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ADMA Short Interest - Frequently Asked Questions What is ADMA Biologics' current short interest? Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 6,720,000 shares of ADMA short. Learn More on ADMA Biologics' current short interest. What is a good short interest ratio for ADMA Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 3.0. Learn More on ADMA Biologics's short interest ratio. Which institutional investors are shorting ADMA Biologics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADMA Biologics: Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ADMA Biologics' short interest increasing or decreasing? ADMA Biologics saw a increase in short interest in February. As of February 29th, there was short interest totaling 6,720,000 shares, an increase of 9.3% from the previous total of 6,150,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ADMA Biologics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to ADMA Biologics: 4D Molecular Therapeutics, Inc. (16.75%), Adaptimmune Therapeutics plc (0.28%), Autolus Therapeutics plc (1.19%), Relay Therapeutics, Inc. (8.39%), CARGO Therapeutics, Inc. (8.46%), Scholar Rock Holding Co. (15.49%), Inhibrx, Inc. (5.48%), BioCryst Pharmaceuticals, Inc. (14.12%), Tarsus Pharmaceuticals, Inc. (17.62%), Immatics (9.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short ADMA Biologics stock? Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ADMA Biologics? A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further. How often is ADMA Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: FDMT Short Squeeze ADAP Short Squeeze AUTL Short Squeeze RLAY Short Squeeze CRGX Short Squeeze SRRK Short Squeeze INBX Short Squeeze BCRX Short Squeeze TARS Short Squeeze IMTX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADMA) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceDid you make $29,000 two days with AI options trades?Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe world’s greatest investmentPorter & Company